Ken Griffin Charles River Laboratories International, Inc. Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 83,000 shares of CRL stock, worth $17.4 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
83,000
Previous 43,600
90.37%
Holding current value
$17.4 Million
Previous $11.8 Million
45.15%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding CRL
# of Institutions
732Shares Held
51.8MCall Options Held
233KPut Options Held
236K-
Vanguard Group Inc Valley Forge, PA6.1MShares$1.28 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$1.07 Billion0.02% of portfolio
-
State Street Corp Boston, MA2.09MShares$438 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.91MShares$400 Million0.99% of portfolio
-
Clearbridge Investments, LLC New York, NY1.37MShares$287 Million0.24% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $10.7B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...